JP2024506291A5 - - Google Patents
Info
- Publication number
- JP2024506291A5 JP2024506291A5 JP2023547188A JP2023547188A JP2024506291A5 JP 2024506291 A5 JP2024506291 A5 JP 2024506291A5 JP 2023547188 A JP2023547188 A JP 2023547188A JP 2023547188 A JP2023547188 A JP 2023547188A JP 2024506291 A5 JP2024506291 A5 JP 2024506291A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- acid
- pharmaceutically acceptable
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163145363P | 2021-02-03 | 2021-02-03 | |
| US63/145,363 | 2021-02-03 | ||
| PCT/US2022/015098 WO2022169962A1 (en) | 2021-02-03 | 2022-02-03 | Formulation of furin inhibitor for inhalation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024506291A JP2024506291A (ja) | 2024-02-13 |
| JP2024506291A5 true JP2024506291A5 (https=) | 2025-02-06 |
Family
ID=80446118
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023547188A Pending JP2024506291A (ja) | 2021-02-03 | 2022-02-03 | 吸入用のフューリンインヒビターの製剤 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20240307374A1 (https=) |
| EP (1) | EP4288052A1 (https=) |
| JP (1) | JP2024506291A (https=) |
| KR (1) | KR20230142752A (https=) |
| CN (1) | CN117222410A (https=) |
| AU (1) | AU2022215580A1 (https=) |
| CA (1) | CA3205921A1 (https=) |
| IL (1) | IL304858A (https=) |
| WO (1) | WO2022169962A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102023126563A1 (de) * | 2023-09-28 | 2025-04-03 | Philipps-Universität Marburg, Körperschaft des öffentlichen Rechts | Hemmstoffe der Proproteinkonvertase Furin, Verfahren zu deren Herstellung und Verwendung |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ535425A (en) | 2002-03-13 | 2008-05-30 | Biogen Idec Inc | Anti-alphavbeta6 antibodies |
| DK2400950T3 (da) * | 2009-02-26 | 2019-07-29 | Glaxo Group Ltd | Farmaceutiske formuleringer omfattende 4-{(1 r)-2-[(6-{2-[(2,6-dichlorbenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl)phenol |
| EP2601973A1 (en) * | 2011-12-09 | 2013-06-12 | Laboratoires SMB SA | Dry powder formulation of azole derivative for inhalation |
| PT3357919T (pt) * | 2014-02-14 | 2020-02-20 | Respivert Ltd | Compostos heterocíclicos aromáticos como compostos antiinflamatórios |
| BR112020022961A2 (pt) | 2018-05-11 | 2021-02-17 | Glaxosmithkline Intellectual Property Development Limited | inibidores de furina |
-
2022
- 2022-02-03 CN CN202280026916.7A patent/CN117222410A/zh active Pending
- 2022-02-03 KR KR1020237029502A patent/KR20230142752A/ko active Pending
- 2022-02-03 CA CA3205921A patent/CA3205921A1/en active Pending
- 2022-02-03 WO PCT/US2022/015098 patent/WO2022169962A1/en not_active Ceased
- 2022-02-03 AU AU2022215580A patent/AU2022215580A1/en not_active Abandoned
- 2022-02-03 EP EP22705656.1A patent/EP4288052A1/en active Pending
- 2022-02-03 US US18/275,531 patent/US20240307374A1/en active Pending
- 2022-02-03 JP JP2023547188A patent/JP2024506291A/ja active Pending
- 2022-02-03 IL IL304858A patent/IL304858A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5286251B2 (ja) | インフルエンザ治療剤 | |
| JP2021063088A5 (https=) | ||
| JP2016534063A5 (https=) | ||
| CN101171005A (zh) | Pde4抑制剂罗氟司特与四氢生物蝶呤衍生物的组合 | |
| EA004657B1 (ru) | Фармацевтическая композиция на основе обладающих антихолинергическим действием соединений , способ ее получения и применение | |
| JP2024170583A5 (https=) | ||
| JP2023110019A5 (https=) | ||
| JP2009537246A5 (https=) | ||
| RU2005100781A (ru) | Комбинация азеластина и стероидов | |
| HRP20171044T1 (hr) | Kemijski i metabolički stabilni dipeptid s potentnom aktivnošću blokatora natrijevog kanala | |
| JP2015500285A5 (https=) | ||
| JP2024544538A5 (https=) | ||
| AU2016202513B2 (en) | Composition | |
| JP2024506291A5 (https=) | ||
| JP5941258B2 (ja) | 他の薬剤と組合せた（ｒ，ｒ）−ホルモテロール | |
| JP2022527401A5 (https=) | ||
| ES2576980T3 (es) | Derivados químicos de jasmonato, composiciones farmacéuticas y métodos de uso de los mismos | |
| PE20030970A1 (es) | Formulacion de aerosol para inhalacion que contiene una sal de tiotropio | |
| JP2022527630A5 (https=) | ||
| JP2013518061A5 (https=) | ||
| WO2005113492A1 (fr) | Sels d'ambroxol analogues de cysteine, procedes d'elaboration et utilisations | |
| JP2008520611A5 (https=) | ||
| JP2023521554A (ja) | 抗ウイルス治療 | |
| JP2009526817A5 (https=) | ||
| JP2024520788A5 (https=) |